Deng Yujie, Chen Xiaohui, Ye Yuhong, Shi Xi, Zhu Kunshou, Huang Liming, Zhang Sheng, Ying Mingang, Lin Xuede
Department of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, PR China; These two authors contributed equally to this paper.
Division of Oncological Surgery, Fujian Provincial Cancer Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, PR China; These two authors contributed equally to this paper.
Contemp Oncol (Pozn). 2016;20(4):311-9. doi: 10.5114/wo.2016.61852. Epub 2016 Sep 5.
To determine the significance of expression of synaptophysin, chromogranin A, and Ki-67 and their association with clinicopathological parameters, and to find out the possible prognostic factors in gastric neuroendocrine carcinoma (G-NEC).
We investigated the immunohistochemical features and prognosis of 62 G-NECs, and evaluated the association among expressions of synaptophysin, chromogranin A, and Ki-67, clinicopathological variables, and outcome.
Chromogranin A expression was found more commonly in small-cell NECs (9/9, 100%) than in large-cell NECs (27/53, 51%) (p = 0.008). No statistical significance was found in Ki-67 (p = 0.494) or synaptophysin (p > 0.1) expression between NEC cell types. Correlation analyses revealed that Ki-67 expression was significantly associated with mid-third disease of stomach (p = 0.005) and vascular involvement (p = 0.006), and had a trend of significant correlation with tumour relapse (p = 0.078). High expression of chromogranin A was significantly associated with histology of small-cell NECs (p = 0.008) and lesser tumour greatest dimension (p = 0.038). The prognostic significance was determined by means of Kaplan-Meier survival estimates and log-rank tests, and as a result, early TNM staging and postoperative chemotherapy were found to be correlated with longer overall survival (p < 0.05). Univariate analysis revealed associations between poor prognosis in NECs and several factors, including high TNM staging (p = 0.048), vascular involvement (p = 0.023), relapse (p = 0.004), and microscopic/macroscopic residual tumour (R1/2, p < 0.001). In a multivariate analysis, relapse was identified as the sole independent prognostic factor.
No significant correlation between survival and expression of synaptophysin, chromogranin A, or Ki-67 has been determined in G-NECs. Our study indicated that early diagnosis, no-residual-tumour resection, and postoperative chemotherapy were possible prognostic factors.
确定突触素、嗜铬粒蛋白A和Ki-67的表达意义及其与临床病理参数的关联,并找出胃神经内分泌癌(G-NEC)可能的预后因素。
我们调查了62例G-NEC的免疫组化特征和预后,并评估了突触素、嗜铬粒蛋白A和Ki-67的表达、临床病理变量与预后之间的关联。
嗜铬粒蛋白A的表达在小细胞NEC中更为常见(9/9,100%),而在大细胞NEC中为(27/53,51%)(p = 0.008)。NEC细胞类型之间的Ki-67(p = 0.494)或突触素(p > 0.1)表达无统计学意义。相关性分析显示,Ki-67表达与胃中三分之一病变(p = 0.005)和血管侵犯(p = 0.006)显著相关,并且与肿瘤复发有显著相关趋势(p = 0.078)。嗜铬粒蛋白A的高表达与小细胞NEC的组织学(p = 0.008)和较小的肿瘤最大径(p = 0.038)显著相关。通过Kaplan-Meier生存估计和对数秩检验确定预后意义,结果发现早期TNM分期和术后化疗与更长的总生存期相关(p < 0.05)。单因素分析显示NEC预后不良与几个因素有关,包括高TNM分期(p = 0.048)、血管侵犯(p = 0.023)、复发(p = 0.004)以及镜下/肉眼残留肿瘤(R1/2,p < 0.001)。在多因素分析中,复发被确定为唯一的独立预后因素。
在G-NEC中,尚未确定突触素、嗜铬粒蛋白A或Ki-67的表达与生存之间存在显著相关性。我们的研究表明,早期诊断、无残留肿瘤切除和术后化疗可能是预后因素。